Related Experiment Video
Updated: Nov 3, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
The predictive value of intraprocedural mitral gradient for outcomes after MitraClip and its peri-interventional
Can Öztürk1, Kim Sprenger1, Noriaki Tabata1
1Department of Cardiology, University Hospital Bonn, Bonn, Germany.
Background:
The current data on the impact of the increased mitral gradient (MG) on outcomes are ambiguous, and intraprocedural assessment of MG can be challenging. Therefore, we aimed to evaluate (a) peri-interventional dynamics of MG, (b) the impact of intraprocedural MG on clinical outcomes, and (c) predictors for unfavorable MG values after MitraClip.
Methods:
We prospectively included patients who underwent MitraClip. All patients underwent echocardiography at baseline, intraprocedurally, at discharge, and after 6 months. 12-month survival was documented.
Results:
One hundred and seventy five patients (age 81.2 ± 8.2 years, 61.2% male) with severe mitral regurgitation (MR) were included. We divided our cohort into two groups according to intraprocedural MG with a threshold of 4.5 mm Hg, determined by a multivariate analysis of predictors for 12-month mortality (<4.5 mm Hg: Group 1, ≥4.5 mm Hg: Group 2). Intraprocedural MG ≥4.5 mm Hg was found to be the strongest independent predictor for 12-month mortality (HR: 2.33, P = .03, OR: 1.70, P = .05), and >3.9 mm Hg was associated with adverse functional outcomes (OR: 1.96, P = .04). The baseline leaflet-to-annulus index >1.1 was found to be the strongest independent predictor (OR: 9.74, P = .001) for unfavorable intraprocedural MG, followed by the number of implanted clips (P = .01), MG at baseline (P = .02), and central clip implantation (P = .05).
Conclusion:
An intraprocedural MG <3.9 mm Hg appears to be the best strategy for 1-year survival and favorable functional outcomes after edge-to-edge MV repair with MitraClip independently from MR etiology. Peri-interventional echocardiographic and procedural parameters are useful for the adequate assessment of intraprocedural MG.
Insights
Maintaining a mitral gradient below 3.9 mm Hg during MitraClip procedures is crucial for 1-year survival and improved functional outcomes. Echocardiography and procedural data help assess this important metric.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- The impact of elevated mitral gradient (MG) on patient outcomes post-MitraClip is unclear.
- Intraprocedural assessment of MG presents significant challenges.
Purpose of the Study:
- To investigate the peri-interventional changes in MG.
- To determine the effect of intraprocedural MG on clinical outcomes.
- To identify predictors of unfavorable MG values after MitraClip implantation.
Main Methods:
- Prospective study of patients undergoing MitraClip.
- Echocardiography performed at baseline, intraprocedurally, at discharge, and 6-month follow-up.
- 12-month survival data collected.
Main Results:
- Intraprocedural MG ≥4.5 mm Hg was the strongest predictor of 12-month mortality (HR: 2.33, P=.03).
- MG >3.9 mm Hg correlated with adverse functional outcomes (OR: 1.96, P=.04).
- Baseline leaflet-to-annulus index >1.1 was the strongest predictor of unfavorable intraprocedural MG (OR: 9.74, P=.001).
Conclusions:
- An intraprocedural MG <3.9 mm Hg is optimal for 1-year survival and functional outcomes after MitraClip.
- Echocardiographic and procedural parameters aid in assessing intraprocedural MG effectively.
More Related Videos
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse III: Nursing Management

